“Global Cell Line Development Services Market, by Product Type (Reagents and Media, Equipment, Accessories and Consumables), By Type (Recombinant Cell Lines, Hybridisms, Continuous Cell Lines, Primary Cell Lines), by Application (Bioproduction, Drug Discovery, Toxicity Testing, Other Applications), by Source (Mammalian Cell Line, Non-Mammalian Cell Line), as well as by Region – Global Forecast 2021 to 2029.”, which offers a comprehensive view of the global cell line development services market through systematic segmentation, covering every aspect of this target market. The 5-year (2021–2026) cumulative revenue of this market is projected to be over USD $1,646.9 Mn, and is estimated to increase significantly over the latter part of the forecast period.
Cell line development requires the discovery of a single cell-derived clones that produce high and consistent levels of the target therapeutic protein. Cell lines have revolutionized scientific research and are presently being used in vaccine production, testing drug metabolism and cytotoxicity, the generation of artificial tissue, the study of gene function, antibody production, etc. Cell line development services enable researchers to benefit from the advantages of comprehensive workflows can begin from the desired gene sequence to the stable cell line, including verification procedures.
The increasing incidence of various disorders such as psoriasis, diabetes, anaemia, Crohn’s disease, rheumatoid arthritis, various cancers, age-related macular degeneration, etc., across the world, as well as the increasing prevalence of immunology disorders among individuals of varying ages is a major factor that is anticipated to continue to fuel the projected revenue growth of the global cell line development services market over the next decade. Moreover, the increasing prominence of biosimilars due to the lower costs required needed as well as shorter durations to develop, is another major factor that is slated to compliment opportunities for additional market growth in the coming years. Furthermore, increasing investments being channelled by key industry players towards improving the development, screening, and manufacturing technologies, as well as the incorporation of automation and robotics in cell line processes are also factor that are slated to influence this global market. In addition, as a result of the COVID-19 outbreak, numerous researchers are now seeking to extensively use these services to develop effective forms of treatment. These aforementioned factors are some of the most crucial elements that are anticipated to play a critical role in edging the projected revenue of the global cell line development services market to USD $2,444.2 Mn by 2029, at a CAGR of 14.2%.
MarketResearch.biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. MarketResearch.biz offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.
Like us on Facebook: https://www.facebook.com/marketresearch.biz
Follow on Twitter+: https://twitter.com/PrudourResearch
420 Lexington Avenue, Suite 300
New York City, NY 10170,
Email ID: email@example.com